Research and Clinical Trials

Dr. Rick Bold, site deputy director for Mayo Clinic Comprehensive Cancer Center in Arizona, discusses breaking down barriers that stand in the way of cancer care.

Dr. Sumera Ilyas discusses the recent advances researchers have made in diagnosing, staging and treating bile duct cancer.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

They identified a cell-signaling protein that drives pancreatic cancer cell growth that could be a potential therapeutic target.

Read about cancer research conducted by scientists at Mayo Clinic Comprehensive Cancer Center over the past year.

The dye reveals any lack of blood flow, indicating a potential problem with tissue, which surgeons can then remove.

Researchers found invasive margins of these brain tumors contain biologically distinct alterations that point to aggressive behavior and recurrence.

Research suggests a risk prediction model calculated with a smartphone app may make surgery safer for liver cancer patients by predicting liver failure after surgery.

Minnesota sisters discover they have a shared genetic mutation that dramatically increases their risk for breast and ovarian cancer.

Associated with relapse-free survival, the genes may play a role in triggering inflammation to initiate an immune system response.